Targeting MYCN and MDM2 offers new hope for cancer therapy
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.